Bajaj HealthCare logo

Bajaj HealthCare

BAJAJHCARE NSE
₹314.45 3.75 (1.21%)
Market Cap
₹1,059 Cr
P/E
54.59

Bajaj HealthCare (BAJAJHCARE) share price was ₹314.45 at the 28 Oct 2026 close; market capitalisation ₹1,059 Cr; P/E (TTM) 54.59; sector Healthcare. The share price fell 30.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 11.3% year on year to ₹165.6 Cr and net profit rose 16.1% year on year to ₹13.7 Cr (compared with Jun 2025). Promoters held 58.59% of Bajaj HealthCare in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 49/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹314.45 −137.10 −30.36% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹1,059 Cr
P/E (TTM)
54.59
EBITDA
₹112 Cr
Return on Equity
4%
Debt to Equity
0.47
Book Value
₹165.51
EPS (TTM)
₹5.76
52W High
₹488.90
52W Low
₹272.35

Price-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,757.5034.864,21,683 Cr5.050.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,558.5086.752,53,748 Cr15.140.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,557.0071.541,73,334 Cr9.430.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,181.90107.801,17,891 Cr22.240.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,175.5026.161,17,257 Cr4.330.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,335.4034.591,11,463 Cr2.870.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.6032.721,10,321 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Bajaj HealthCare (this company)
₹314.4554.591,059 Cr1.900.48%4.00%8.34%662 Cr18 Cr
Median 8 companies₹1,561.5544.731,17,574 Cr4.690.54%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
49 Average
Overall score
Data confidence 100/100

Category scores

Quality Good 64
Returns, margins, earnings quality 22%
Valuation Average 54
Cheap vs sector & own history 24%
Growth Weak 43
Sales & profit trajectory 9%
Financial Health Poor 32
Solvency, leverage, coverage 9%
Momentum Poor 31
Trend strength, vol-adjusted 12%
Ownership Weak 44
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

5
  • The company has delivered a poor sales growth of -1.44% over past five years.
  • Company has a low return on equity of 3.48% over last 3 years.
  • Dividend payout has been low at 12.2% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -9.10%
  • Working capital days have increased from 90.8 days to 132 days

Technical Indicators

Oscillators

BearishNeutralBullish

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
10% higher than 3Y

change over 1 year

Net Income Growth
-50.35% lower than 3Y

change over 1 year

Cash Flow Change
169%

change over 1 year

EBITDA Margin Change
-0.06%

change over 1 year Operating margin 17% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
130
101
109
134
132
133
123
154
149
148
161
153
166
Expenses
108
82
89
118
108
109
101
143
124
121
131
130
137
Operating Profit
22
19
20
16
24
25
22
12
25
27
31
23
29
OPM %
17%
19%
18%
12%
19%
18%
18%
8%
16%
18%
19%
15%
17%
Other Income
-55
-7
-7
-36
0
4
-1
13
1
0
1
-34
1
Interest
9
8
7
6
8
8
6
6
5
6
6
6
6
Depreciation
6
7
7
7
7
7
7
8
6
7
7
8
7
PBT
-48
-3
-1
-33
9
14
8
11
14
15
19
-24
16
Tax %
0%
4%
58%
-10%
23%
30%
-39%
1%
17%
24%
17%
-6%
16%
Net Profit
-48
-3
-2
-30
7
9
12
11
12
11
16
-23
14
EPS (₹)
-17.47
-1.25
-0.8
-10.84
2.58
3
3.71
3.54
3.75
3.52
4.96
-6.79
4.07
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
218
223
231
327
370
410
657
680
646
473
543
611
628
Expenses
189
193
200
288
327
362
521
561
534
397
460
506
519
Operating Profit
29
30
31
39
43
48
136
119
112
76
83
105
109
OPM %
13%
14%
13%
12%
12%
12%
21%
17%
17%
16%
15%
17%
17%
Other Income
0
0
2
2
1
7
7
1
-19
-105
16
-32
-32
Interest
8
8
8
8
8
7
8
13
18
30
28
22
23
Depreciation
9
9
11
11
11
12
16
18
17
28
28
28
29
PBT
12
14
14
23
24
36
119
90
58
-86
43
23
25
Tax %
37%
39%
43%
33%
33%
30%
30%
20%
25%
-3%
7%
33%
—
Net Profit
8
8
8
15
16
25
83
71
43
-84
40
16
18
EPS (₹)
8.34
3.04
2.83
5.5
5.91
9.14
30.11
25.87
15.59
-30.36
12.51
4.68
5.76
Div. Payout %
0%
0%
0%
5%
0%
0%
5%
6%
6%
-3%
8%
32%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
7
7
7
7
14
14
14
14
14
16
17
Reserves
78
82
92
107
122
164
245
315
354
265
450
516
Borrowings
70
81
75
87
81
91
181
257
415
333
223
249
Other Liabilities
38
39
45
68
57
74
86
136
115
154
144
141
Total Liabilities
189
209
219
268
267
343
526
721
898
765
833
923
Fixed Assets
108
130
128
127
128
162
208
270
366
253
238
248
CWIP
1
1
0
2
1
5
57
52
22
7
3
8
Investments
0
0
0
0
0
5
0
0
0
0
0
0
Other Assets
79
78
91
140
137
170
260
399
510
506
591
667
Total Assets
189
209
219
268
267
343
526
721
898
765
833
923
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
28
25
22
17
25
21
44
1
-22
92
22
58
Investing
-17
-31
-8
-12
-13
-28
-109
-75
-93
-11
-15
-48
Financing
-11
5
-13
2
-13
3
75
62
131
-97
-6
24
Net Cash Flow
0
0
0
7
0
-4
10
-12
16
-16
0
35
Free Cash Flow
11
-6
14
5
11
-2
-70
-74
-115
73
10
18
CFO/OP
99
100
88
57
89
62
58
9
-10
138
32
53
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
86
70
83
90
77
88
55
99
110
139
169
140
Inventory Days
50
56
45
57
45
54
94
143
199
206
206
249
Days Payable
63
46
51
74
45
80
67
94
81
128
127
133
Cash Conversion Cycle
73
80
78
73
77
62
82
148
228
217
248
256
Working Capital Days
-11
-17
-4
0
12
24
34
40
27
0
141
132
ROCE %
16%
13%
13%
16%
16%
18%
36%
20%
14%
8%
11%
11%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Bajaj HealthCare insights

71 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

DIIs1.96%Promot.58.59%FIIs2.09%Others6.55%Public30.81%As ofSep 2026

Documents

Frequently Asked Questions about Bajaj HealthCare

What does Bajaj Healthcare Ltd do?
Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations[1]
Where is Bajaj Healthcare Ltd (BAJAJHCARE) listed?
Bajaj Healthcare Ltd trades as BAJAJHCARE on the NSE and under code 539872 on the BSE.
Which sector does Bajaj Healthcare Ltd belong to?
Bajaj Healthcare Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd has a market capitalisation of ₹1,059 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd trades at a PE ratio of 54.59 as of 28 Oct 2026, on earnings per share of ₹5.76, against a book value of ₹165.51 per share.
What is the 52-week high and low of Bajaj Healthcare Ltd?
Over the last 52 weeks Bajaj Healthcare Ltd has traded between ₹272.35 and ₹488.9 as of 28 Oct 2026.
Does Bajaj Healthcare Ltd pay dividends?
Bajaj Healthcare Ltd has a dividend yield of 0.48%.
What is the Return on Equity (ROE) of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd reported a return on equity of 4.00%. Its debt-to-equity ratio is 0.47.

Company Information

Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations[1]

Website bajajhealth.com
CEO Mr. Sajankumar Rameshwarlal Bajaj
Employees 918
Listed 2021-11-25
Face Value ₹ 5
Shares Outstanding 3,36,65,161

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BAJAJHCARE.md for Bajaj Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month